Hornbill Orchid India Fund has secured 12.66 lakh shares, which is 20.21% of the anchor allocation and an investment of Rs 10 crore. Carnelian India Multi Strategy Fund was allotted 12.65 lakh shares, representing 20.2% of the anchor portion and worth Rs 10 crore.
The anchor placement comes a day before the public issue opens for subscription on February 20 and closes on February 24. The price band for the IPO has been set at Rs 75 to Rs 79 per share.
Gaudium IVF’s IPO is a combination of a fresh issue of Rs 90 crore and an offer for sale of 94,93,700 equity shares worth Rs 75 crore, taking the total issue size to Rs 165 crore.
It is proposed that the net proceeds from the new issue will be used mainly for expansion and debt reduction. About Rs 50 crore will be deployed for setting up new IVF centres, while Rs 20 crore will go towards repayment or prepayment of certain outstanding loans. The balance will be used for general corporate purposes.
Retail investors can apply for a minimum of 189 shares, which requires an investment of Rs 14,931 in the higher price band. The issuance structure provides that not more than 50% of the net issuance will be allocated to qualified institutional buyers, not less than 35% to retail investors and not less than 15% to non-institutional investors. Gaudium IVF and Women Health Ltd operate in the assisted reproductive technology segment, offering services such as IVF, ICSI, IUI and ovulation induction, along with gynecological care and high-risk pregnancy management. The company follows a hub-and-spoke model and currently operates over 30 locations including seven hub centers and 28 spokes across India.
Financially, Gaudium IVF has reported steady growth. For the year ended March 2025, the company posted a total income of Rs 70.96 crore and a profit after tax of Rs 19.13 crore.
#Gaudium #IVF #raises #crore #anchor #ahead #IPO #opening #tomorrow #Check #main #investors